Found 7 matching trials
A 12-month Real Life Study of IBD Patients Switched From Adalimumab Originator Humira® to One of Its Biosimilar
N/ABiosimilars represent great potential in cost saving and reinvestment oppor...
Location
Chu Grenoble Alpes
REduCed Dose of TNFi in Patients With Ankylosing SpondyliTis (RECAST)
PHASE4Participants maintaining stable disease activity of Ankylosing Spondylitis ...
Location
Multiple Locations
SKIN Disease Profiling by an Exploratory, pRospective, Biomarker Study in dermatoloGY Practice (SKINERGY)
N/AThe goal of this observational study is to comprehensively profile six immu...
Location
Radboud University Medical Center
Pharmacokinetics, Safety and Tolerability Study of AVT02 to EU-approved and US-licensed Humira (Adalimumab)
PHASE1This study has been designed as a multicentre, randomised, double-blind stu...
Location
Scientia Clinical Research
PK, Safety and Tolerability Study of AVT02 (Adalimumab) Pre-filled Syringe (PFS) vs, AVT02 Autoinjector (AI)
PHASE1This study has been designed as a multicentre, randomised, open label study...
Location
Christchurch Clinical Studies Trust Limited
A Study of JNJ-64304500 as Add-on Therapy in Participants With Active Crohn's Disease
PHASE2The purpose of this study is to evaluate the efficacy and safety of JNJ-643...
Location
Medisphere Medical Research Center, Llc
A Trial of Academic Detailing to Promote Prescribing of Biosimilars
NAThe goal of this trial is to learn if an interactive evidence-based educati...
Status
Active Not Recruiting
Location
Humana Healthcare Research, Inc.